Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies April 24, 2024
- 4 Key Components to a Winning Go-To-Market Strategy April 24, 2024
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Four Things to Know About The Monoclonal Antibodies – “mAbs” Market
Kalorama Information notes 4 trends in monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells that seek out and destroy harmful foreign substances – topped $100 billion in 2017, according to Kalorama Information What’s Trending in Monoclonal Antibodies, examines the several types of monoclonal antibodies on the market and in development, looking at […]
Severe Flu Season Provides an Opportunity for Molecular POC
It’s late January, 2018. It’s the centenary of the opening salvos of the “Spanish” Flu Pandemic, the unsung (and misnomered) villain of the later days of The Great War. With cases on the rise right now, the 2017-’18 flu season has yet to reach its peak[1], surpassing that of the 2012-’13 season, and young people […]
Top 10 Companies in Liquid Biopsy Detailed in New Report
New York City-based healthcare market researcher Kalorama Information details the top 10 liquid biopsy companies and their activities in a new report. The market, Kalorama says, is heterogeneous and very fragmented, with many companies commercializing various liquid biopsy diagnostic products and developing new ones for a broad range of applications. But a few top competitors […]
Promise of Fast Growth Propels Molecular Technologies in Fighting Infections
Make sure to visit our In Vitro Diagnostics page, Kalorama’s all-in-one resource covering the IVD market. Infectious Disease Molecular IVD Market: Fastest Growth of Any Molecular Test Segment Infectious Disease is the best-selling and fastest-growing part of molecular testing, as Kalorama notes in its report Infectious Disease Diagnostics. Molecular diagnostics’ performance and applicability is unparalleled among IVD […]
Qiagen Adds to Leading Molecular Cancer Menu with FDA-Cleared JAK2 Test Kit
Prognostic and Other Evaluative Tests Kits Join Companion Diagnostics in U.S. Cancer Diagnostics. Kalorama Information covers molecular in vitro diagnostics (IVD) markets for cancer and blood disorders inThe World Molecular Diagnostics Market, 7th Ed. The U.S. Food and Drug Administration (FDA) recently cleared Qiagen’s ipsogen JAK2 RGQ PCR Kit for detection of the V617F mutation on […]
Molecular Diagnostics Faces Competition for Future Point of Care Testing in Developing World
Multiplex Immunoassays Could Develop as a Cheaper Panel Testing Option for Tropical Diseases Kalorama Information reports cover the related global markets for point of care (POC) diagnostics and molecular POC diagnostics. Make sure to visit our Point of Care Testing page, Kalorama’s all-in-one resource covering the POC testing market. The sensitivity and specificity of nucleic acid analytes provide molecular […]
Recent Autism Test Studies Add to Promising, Yet Inconclusive Research into Psychiatric Diagnostics
Kalorama Information covers in vitro diagnostics (IVD) markets for autism spectrum disorders (ASDs) and other psychiatric disorders in The World Molecular Diagnostics Market, 7thEd. and Novel Autism Diagnostics. In two recent studies, in vitro diagnostic (IVD) assays have been investigated that incorporate biomarkers for environmental factors and dysfunctional cellular pathways associated with autism spectrum disorders (ASDs). The accuracy […]
Drive for Prevention to Fuel Food Safety Diagnostics
This article is based on information in Kalorama Information’s Food Safety Diagnostics Market Report (https://www. kaloramainformation.com/Food- Safety-Diagnostics-12090767/ ). Food safety concerns are increasing globally as international food trading is growing at a fast pace. Industrialization of food consumption is another major trend in many countries including several emerging markets, which in turn is pushing the growth of international […]
Recent Companion Dx Deals
Companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes. Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit from the […]
IVD in 2019: Eight Out-of-the-Box Predictions
Kalorama Information is the Publisher of The Worldwide Market for In Vitro Diagnostics, 11th Edition, the definitive report on the IVD market. Based on our 2018 research, here are 8 little-discussed trends that we expect to unfold in 2019: 1 Another Year of “Prove to Play” for Tests– Yes, your new 2019 diagnostic test product will be […]